Functional significance of repressor element 1 silencing transcription factor (REST) target genes in pancreatic beta cells by Martin,  D. et al.
ARTICLE
Functional significance of repressor element 1 silencing
transcription factor (REST) target genes in pancreatic
beta cells
D. Martin & F. Allagnat & G. Chaffard & D. Caille &
M. Fukuda & R. Regazzi & A. Abderrahmani &
G. Waeber & P. Meda & P. Maechler & J.-A. Haefliger
Received: 17 October 2007 /Accepted: 19 February 2008 /Published online: 3 April 2008
# Springer-Verlag 2008
Abstract
Aims/hypothesis The expression of several neuronal genes
in pancreatic beta cells is due to the absence of the tran-
scription factor repressor element 1 (RE-1) silencing tran-
scription factor (REST). The identification of these traits and
their functional significance in beta cells has only been partly
elucidated. Herein, we investigated the biological conse-
quences of a repression of REST target genes by expressing
REST in beta cells.
Methods The effect of REST expression on glucose homeo-
stasis, insulin content and release, and beta cell mass was
analysed in transgenic mice selectively expressing REST in
beta cells. Relevant target genes were identified in INS-1E
and primary beta cells expressing REST.
Results Transgenic mice featuring a beta cell-targeted ex-
pression of REST exhibited glucose intolerance and reduced
beta cell mass. In primary beta cells, REST repressed several
proteins of the exocytotic machinery, including synapto-
somal-associated protein (SNAP) 25, synaptotagmin (SYT)
IV, SYT VII, SYT IX and complexin II; it impaired first and
second phases of insulin secretion. Using RNA interference
in INS-1E cells, we showed that SYT IV and SYT VII were
implicated in the control of insulin release.
Conclusions/interpretation The data document the critical
role of REST target genes in pancreatic beta cells. Specif-
ically, we provide evidence that the downregulation of these
genes is detrimental for the exocytosis of large dense core
vesicles, thus contributing to beta cell dysfunction and im-
paired glucose homeostasis.
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Ad-GFP GFP-encoding adenovirus
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IBMX 3-isobutyl-1-methylxanthine
IPGTT intraperitoneal glucose tolerance test
KRBH KRB HEPES
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LDCV large dense core vesicles
MUNC-18–1 UNC-18 homologue 1
NSF N-ethylmaleimide-sensitive factor
RE-1 repressor element 1
REST RE-1 silencing transcription factor
RIP II rat insulin II promoter
siRNA small interfering RNA
SNAP synaptosomal-associated protein
SNARE soluble N-ethylmaleimide-sensitive factor
attachment protein receptor
SREBP-1 sterol regulatory element-binding protein-1
SYT synaptotagmin
Introduction
The transcription factor repressor element 1 (RE-1) silencing
transcription factor (REST), also known as neuron-restrictive
silencing factor, has been implicated in the control of glucose-
induced insulin secretion in the βTC3 cell line [1]. This GLI-
Kruppel zinc finger transcription factor was first described as
a silencer of neuronal genes outside the central nervous
system, since its expression is restricted to non-neuronal
cells and undifferentiated neural progenitors, allowing genes
encoding fundamental neuronal traits to be exclusively
expressed in mature neurons [2, 3]. Target genes possess a
21 bp cis element called RE-1 or neuron restrictive silencer
element, to which REST binds to inhibit expression. Initial
studies indicated that many REST target genes contribute to
synaptic plasticity/remodelling, inasmuch as REST regulates
the expression of synaptic vesicle proteins [4], voltage-
sensitive ion channels [2] and neurotransmitter receptors [5,
6]. However, increasing evidence suggests that the signifi-
cance of the REST/RE-1 system is diverse in embryonic and
adult cells and depends on the range of target genes that
REST interacts with. Accordingly, a bioinformatic analysis
recently revealed about 1,800 putative REST target genes
within the human genome, with attributed roles ranging from
transcriptional regulation through to metabolism and various
aspects of neuronal function [7]. Previous reports have
identified some of these target genes and their function in
and outside the nervous system. Thus, it is now documented
that REST target genes are involved in the reactivation of the
fetal cardiac gene programme in hypertrophied and failing
hearts [8], and modulate the vascular plasticity/remodelling
of human neointimal hyperplasia [9].
Pancreatic beta cells, which lack REST [10], also express
a number of REST target genes. However, it remains to be
established how these genes participate in beta cell function.
Investigating this molecular mechanism, we previously
showed that in beta cells REST controls the expression of
two neuron-specific genes that code for connexin 36 (CX36),
a gap junction-forming protein participating in control of
insulin secretion [11], and islet brain-1, a scaffold protein
protecting beta cells against apoptosis via the c-Jun N-
terminal kinase signalling pathway [12]. Since the whole set
of REST target genes is involved in the control of insulin
secretion in vitro [1], we have now examined the in vivo
consequences of a gain of function of REST and have iden-
tified additional target genes that are significant to beta cell
function. We show that transgenic mice specifically express-
ing REST in beta cells exhibit glucose intolerance and de-
fective insulin release. We further demonstrate that REST
expression affects both triggering and amplifying pathways
of insulin secretion, by impairing the expression of proteins
of the exocytotic machinery, including the hitherto neglected
synaptotagmin (SYT) IV and VII. These data demonstrate
the crucial role of REST targets in the control of insulin
release and suggest that the downregulation of these genes
may contribute to the pathophysiology of beta cell defects.
Methods
Transgenic mice Transgenic mice specifically expressing
REST in the beta cells were obtained by pronuclear in-
jection of C57Bl/6 zygotes with a SacII/XhoI fragment
consisting of 660 bp of the rat insulin II promoter (RIP II)
[13], separated from the full length human REST cDNA
[12] by the rabbit β-globin intron (Fig. 1a). Three positive
founder mice were successfully bred with C57BL/6 control
mice to generate transgenic animals. Our institutional
review committee for animal experiments approved all the
procedures for mice care, surgery and animal killing.
Immunohistochemistry Pancreases were fixed in 4% (wt/vol.)
paraformaldehyde, equilibrated overnight in 15% (wt/vol.)
sucrose, embedded in 15% sucrose–7.5% (wt/vol.) gelatin
and quickly frozen in methylbutane/liquid nitrogen. Cryosec-
tions were incubated overnight at 4°C with either polyclonal
rabbit antibodies against human RESTor polyclonal guinea pig
antibodies against insulin. Primary antibodies were detected
using appropriate fluorescein or rhodamine-conjugated anti-
bodies. Sections were viewed on a fluorescence microscope
(Leica, Nidau, Switzerland).
Electron microscopy Pancreas fragments were fixed in a
2.5% (vol./vol.) glutaraldehyde solution in 0.1 mol/l phos-
phate buffer (pH 7.4), postfixed in 1% (wt/vol.) osmium
tetroxide in the same buffer, dehydrated and embedded in
Epon [14]. Thin sections were examined in a Philips CM10
electron microscope (Philips, Eindhoven, the Netherlands).
Glucose tolerance and plasma insulin Male mice of 12 to
16 weeks were fasted for 14 h before blood samples were
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collected from the tail vein at 0 (fasting blood sample), 15, 30
and 120min after an intraperitoneal injection of glucose (2 g/kg
body weight as a 20% solution). Blood glucose levels were
measured with a Glucometer (Bayer Healthcare, Zurich,
Switzerland). Plasma insulin levels from the same time points
were determined by ELISA (Mercodia, Uppsala, Sweden).
Cell line and mouse islet isolation The rat insulinoma cell
line INS-1E was maintained in RPMI 1640 medium, as
previously described [15]. Islets of Langerhans of adult
C57BL/6 male mice, weighing 25 to 30 g, were isolated
and cultured as previously described [15].
Insulin secretion INS-1E cells were seeded in 12-well plates
and cultured for 48 h. Isolated islets were cultured overnight
in non adherent dishes. Cells and islets were infected with
adenoviruses as previously described [11], with a multiplicity
of infection of 10 and 15, respectively. As judged by immu-
nofluorescence and quantitative PCR detection of the REST
transgene, this procedure typically resulted in the efficient
transduction of 70 to 80% INS-1E cells and 30 to 40%
primary islet cells. Insulin secretion of INS-1E cells and mouse
islets perifusion were assessed in KRB–HEPES (KRBH)
supplemented with the indicated stimuli, as published [16].
When 30 mmol/l KCl was added in the experiments testing
diazoxide, the NaCl concentration of the medium was reduced
to 105 mmol/l. Glucose, leucine, β-2-aminobicyclo [2.2.1]
heptane-2-carboxylic acid (BCH), forskolin, 3-isobutyl-1-
methylxanthine (IBMX) and diazoxide were purchased from
Sigma (Fluka Chemie, Buchs, Switzerland).
Cell and mitochondrial membrane potentials INS1-E cell
and mitochondrial membrane potentials were monitored
using 100 nmol/l bis-oxonol and 10 μg/ml rhodamine-123
(Molecular Probes, Eugene, OR, USA), respectively, as
previously described [17].
Calcium measurements Cytosolic calcium was monitored in
INS-1E cells loaded for 90 min with 2 μmol/l Fura-2AM
(Teflab, Austin, TX, USA) in KRBH at 37°C. Ratiometric
measurements of Fura-2 fluorescencewere performed in a plate-
reader fluorimeter (Fluostar Optima; BMG Labtechnologies,
Offenburg, Germany) with filters set at 340/380 nm for
excitation and 510 nm for emission.
Chromatin immunoprecipitation assay INS-1E cells were
cross-linked with 1% (wt/vol.) formaldehyde for 30 min and
the reaction was stopped by addition of 0.125 mol/l glycine.
Pelleted cells were lysed in an SDS buffer and submitted to
sonication to obtain the desired chromatin length (~500 bp).
Chromatin was precleared by addition of blocked protein A
Sepharose (Amersham Bioscience Europe, Otelfingen, Swit-
zerland) and the supernatants were immunoprecipitated
overnight at 4°C with either polyclonal rabbit antibodies
specific to human REST [11] or to irrelevant sterol regulatory
element-binding protein-1 (SREBP-1) (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA). The protein–antibody com-
plexes were collected by addition of protein A Sepharose for
1 h and then washed. The protein–DNA complexes were
eluted, treated with RNAseA and proteinase K and then the
cross-links were reversed overnight at 65°C. DNA was
submitted to PCR amplification of rat RE-1 flanking
Fig. 1 Generation of transgenic mice expressing REST in beta cells. a
The construct used to generate RIP–REST transgenic mice contained
the full-length human REST cDNA, surrounded by rabbit β-globin
intronic and polyadenylation sequences, and fused to the RIP II. Solid
bars, the nine-zinc fingers; ATG, start codon of human REST cDNA. b
RIP–REST mice featured morphologically normal pancreatic islets.
Immunostaining using specific antibodies against human REST (in
green) and insulin (in red) demonstrated that REST was specifically
produced in the nucleus of beta cells of heterozygous (Het) RIP–
REST but not wild-type (WT) mice. The corresponding insulin
staining (Ins) is shown. Scale bar, 30 μm. c Quantitative RT-PCR
analysis of mRNA levels of murine and human REST in RIP–REST
mice. White columns show levels of endogenous murine Rest. The
black column shows levels of the human REST transgene. No human
REST expression was found outside pancreatic islets. Results are
means±SEM of four independent experiments. *p<0.05, ***p<0.001
versus values for human REST mRNA levels
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sequences using specific primers (see Electronic supplemen-
tary material [ESM] Table 1).
RNA isolation and northern blotting RNA isolation and
northern blot analysis were performed as previously de-
scribed [15]. Transcripts levels were revealed using specific
probes for rat Cx36 (also known as Gja9), β-actin [11], rat
Munc18-1 (also known as Stxbp1), Syntaxin 1A and Rab3a.
For the other genes, probes were obtained with cDNA from
INS-1E cells or rat brain, which was amplified with specific
primers (ESM Table 2).
Real-time RT-PCR Quantitative RT-PCR was performed
using a kit (SYBR Premix Ex Taq PCR Kit TaKaRa; Axon
Lab, Le Mont-sur-Lausanne, Switzerland) in a Lightcycler
(Roche Diagnostics, Mannheim, Germany), as previously
described [15]. cDNAs were amplified using specific
primers (ESM Table 3).
Western blotting Western blots were performed as previ-
ously described [15]. Specific protein levels were revealed
with polyclonal rabbit antibodies against: CX36 [11],
synaptosomal-associated protein (SNAP) 25 (kindly pro-
vided by H. Hirling, EPFL, Lausanne, Switzerland) and
SYT IV. Monoclonal antibodies against β-actin (Fluka
Chemie) were used to normalise the signals.
SYT IV, SYT VII and REST silencing vectors Specific small
interfering RNA (siRNA) were designed as follows: for rat
Syt4, the sense target sequence 5′GAAGCACAAAGT
GAAAACCA3′ was deduced from the reported mouse
sequence [18]; for rat Syt7 the sense sequence 5′TCAT
CACCGTCAGCCTTAG3′ was selected according to a
previous publication [19]; for REST, the sense sequence 5′
GGAACCTGTTGAGAAGGGA3′ was selected using the
siRNA Target Finder (Ambion, Austin, TX, USA). Two
complementary DNA fragments encoding the target se-
quence and separated from the reverse complement by a
short spacer were synthesised by Microsynth (Balgach,
Switzerland). The two fragments were annealed and cloned
downstream of the H1-RNA promoter of the pSuper vector,
using BglII–HindIII sites. BamHI–HindIII fragments con-
taining the siRNA constructs were subcloned in a plasmid
(pXGH) encoding human growth hormone (hGH).
Human growth hormone secretion INS-1E cells were
transiently transfected with the pXGH vector to use hGH
as a reporter for secretion or with the pXGH containing one
of the specific siRNAs. At 72 h after transfection, secretion
was assessed in KRBH supplemented with 20 mmol/
l glucose, 10 μmol/l forskolin and 100 μmol/l IBMX, and
measured as published [20].
Statistical analysis Data were expressed as mean±SD or
SEM. Differences between means were assessed using
Student’s t test. Statistical significance was defined at a
value of p<0.05, p<0.01 and p<0.001.
Results
Transgenic mice featuring a beta cell-targeted expression
of REST exhibit reduced insulin content and altered
tolerance to glucose To generate transgenic mice producing
REST in pancreatic beta cells, we inserted a transgene
consisting of the RIP II upstream of the full-length human
REST cDNA (Fig. 1a). Examination of pancreas sections
revealed morphologically normal islets in both wild-type
and RIP–REST mice. However, in contrast to their control
littermates, RIP–REST mice produced REST in the nuclei
of the islets of Langerhans (Fig. 1b). Parallel immunostain-
ing of insulin (Fig. 1b) confirmed that this expression was
restricted to beta cells. Quantification of mRNA by real-
time PCR revealed that levels of the human REST transgene
achieved in the islets of RIP–REST mice were comparable
to those of endogenous Rest in kidney. In contrast, no
expression of the REST transgene was detected in the other
tested organs (Fig. 1c). Amuch lower expression of the native
murine Rest was detected in brain and islets, probably re-
flecting the non-neuroendocrine cells of these organs (Fig. 1c).
Electron microscopy revealed normal distribution of the insu-
lin-containing beta cells within the islets of both wild-type
(Fig. 2a) and RIP–REST heterozygous littermates (Fig. 2b)
and also normal appearance of these beta cells, which in both
types of animals were packed with typical, dense-core and
white halo secretory granules (Fig. 2c,d). Further morpho-
logical analyses showed that the numerical density of islets
was similar in the pancreas of control and transgenic mice.
However, the numerical density of beta cells, expressed as
the ratio of total beta cell number to the total pancreas area,
was reduced in RIP–REST mice (Table 1). Accordingly, the
total insulin content of pancreas was twofold lower (p<
0.01) in transgenic than in wild-type littermates (Table 1).
The ability of RIP–REST mice to regulate blood glucose
levels was assessed in 3-month-old male animals during an
intraperitoneal glucose tolerance test (IPGTT) (Fig. 3a).
Compared with wild-type littermates, RIP–REST animals
showed a significantly higher blood glucose concentration at
15 (p<0.05), 30 (p<0.01) and 60 min after glucose injection
(p<0.001). Parallel measurements of plasma insulin levels
revealed similar fasting levels in control and RIP–REST
mice (Fig. 3b). However, the release of insulin in the latter
was significantly reduced at 15 (p<0.05) and 30 min (p<
0.01) after glucose challenging (Fig. 3b). These data show
that RIP–REST mice have reduced levels of pancreatic
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insulin and are intolerant to glucose due to impaired secre-
tory function of beta cells.
REST target genes are crucial for both first and second
phases of insulin secretion To investigate this impairment,
INS-1E-cells were infected with REST-encoding adenovirus
(Ad-REST). Compared with control green fluorescent protein
(GFP) transduction (Ad-GFP), ectopic REST expression did
not alter insulin content (400±60 vs 423±39.6 pmol/l, in
GFP and REST-transduced cells, respectively) or basal insu-
lin secretion (ESM Fig. 1). In contrast, it reduced insulin
release in response to stimulating concentrations of either
glucose, KCl or leucine, compared with GFP-transduced
cells (ESM Fig. 1a). These data show that the KATP channel-
dependent pathway of insulin secretion, triggered by KCl, as
Fig. 3 RIP–REST mice are intolerant to glucose. a Blood glucose
levels in 3-month-old wild-type (solid symbols) males (n=10) and
heterozygous RIP–REST (open symbols) littermates (n=16) during an
IPGTT. After 14 h fasting, blood samples were taken before (t=0) and
after (t=15, 30, 60 and 120 min) intraperitoneal injection of glucose
(2 g/kg). Results are mean±SEM. *p<0.05, **p<0.01, *** p<0.001.
b Plasma insulin levels were measured in 3-month-old male wild-type
(solid symbols) (n=6) and RIP–REST (open symbols) (n=6) mice.
Blood samples were taken at 0, 15, 30 and 120 min of the IPGTT.
Results are mean±SEM. *p<0.05, **p<0.01
Fig. 2 RIP–REST mice feature ultrastructurally normal beta cells.
Electron microscopy revealed normal organisation of beta cells within
pancreatic islets of wild-type (a) and RIP–REST heterozygous
littermates (b). Beta cells from wild-type (c) and RIP–REST mice
(d) featured normal appearance and were packed with typical, dense-
core and white halo secretory granules. Bar: 5 μm (a, b), 1.2 μm (c, d)
Table 1 Morphometric analysis of pancreas
Group Pancreas weight (mg) Insulin content
(pmol/mg pancreas)
Islet numerical density
(n per cm2)
Beta cell numerical density
(n per cm2)
Wild-type 239±22 26±0.23 62.1±2.6 4,084±483
RIP–REST 228±13 13±0.28** 65.7±8.4 2,688±337*
Values are expressed as mean±SD
Number of mice per group: 4
*p<0.05, **p<0.01 versus WT
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well as the KATP channel-independent pathway, triggered by
the non-metabolisable leucine analogue BCH [21], were
both decreased in cells expressing REST. In the diazoxide
experiments, the cells, in presence of 250 μmol/l diazoxide
and 30 mmol/l KCl, were stimulated with 2.5 mmol/l glucose
and then with 15 mmol/l glucose. The second incubation at
15 mmol/l glucose, reflecting the amplifying effect of the
sugar on insulin secretion [22], was significantly reduced in
REST-expressing INS-1E cells (ESM Fig. 1a). Similar ob-
servations were made in REST and GFP-transduced mouse
islets (ESM Fig. 1b), which also featured similar insulin
contents (73.8±6.4 vs 66.9±5.4 pmol/l, in GFP and REST-
transduced islets, respectively).
To ascertain whether RESTaffected both phases of insulin
secretion, we perifused transduced mouse islets (Fig. 4a) and
islets isolated from RIP–REST mice (Fig. 4b). Stimulation
by 20 mmol/l glucose confirmed the REST-induced gene-
ralised impairment (p<0.05) of the stimulus–secretion
coupling during both first (time points 20 to 27 min) and
second phases (time points 28 to 44 min).
REST does not affect plasma and mitochondrial membrane
potentials or intracellular levels of Ca2+ To investigate the
intracellular signalling leading to altered insulin release of
REST-expressing INS-1E cells, we first studied the hyper-
polarisation of the mitochondrial membrane, which results
from the activation of mitochondrial metabolism. This
hyperpolarisation induced by glucose was not affected when
cells were infected with Ad-REST (ESM Fig. 2a). We then
evaluated the cell membrane depolarisation resulting from
the ATP-dependent closure of KATP channels. INS-1E cells
expressing REST depolarised normally under glucose
stimulation (ESM Fig. 2b). Since membrane depolarisation
triggers Ca2+ influx through voltage-gated Ca2+ channels,
we measured the cytoplasmic levels of this cation. We found
that the expression of REST did not affect the glucose-
induced increase in intracellular Ca2+ (ESM Fig. 2c). These
data suggest that REST does not alter the intracellular
signalling that is activated by mitochondrial metabolism and
leads to closure of KATP channels, cell membrane depolar-
isation and elevation of cytosolic Ca2+.
Identification of functional RE-1 sequences We hypothes-
ised that REST controls the expression of genes acting
downstream of the elevation of intracellular Ca2+ and therefore
selected, in a RE-1 database (http://www.bioinformatics.leeds.
ac.uk/cgi-bin/RE1db/nrse.cgi) [7], the following putative
targets: (1) the gene encoding the soluble N-ethylmaleimide-
sensitive factor attachment protein receptor (SNARE) protein
SNAP25, which contains two consecutive RE-1s, referred to
as RE-1.1 and RE-1.2 [7]; (2) the genes encoding the
members of the Ca2+ sensor synaptotagmin family SYT II,
SYT IV, SYT VI, SYT VII, SYT IX; and (3) the genes
coding for the N-ethylmaleimide-sensitive factor (NSF), for
UNC-18 homologue 1 (MUNC-18-1) and for complexin II,
which participate in the formation and stabilisation of the
SNARE complex. The 21 bp human RE-1 sequences
associated to these genes were compared with those of
consensus RE-1 and of the known CX36 RE-1 [11]. All
sequences, except that of MUNC18-1, were closely homol-
ogous to the consensus one and displayed a typical core [23]
consisting of two invariant domains (Fig. 5a).
The in situ binding activity of these RE-1s in REST-
expressing INS-1E cells was assessed by a chromatin
Fig. 4 Repression of REST target genes impairs the two phases of
insulin release. a Insulin release of mouse islets transduced with Ad-
GFP (dashed lines) and Ad-REST (solid lines) during perifusion
experiments. After a 15 min period in presence of 2.5 mmol/l glucose,
islets were stimulated for 30 min with 20 mmol/l glucose and then
returned to 2.5 mmol/l glucose for 15 min. Values are means±SEM. of
three independent experiments. *p<0.05 for corresponding time
points. b Insulin release of islets isolated from wild-type (dashed
lines) and RIP–REST (solid lines) mice during perifusion experi-
ments. After a 15 min period in presence of 2.5 mmol/l glucose, islets
were stimulated for 30 min with 20 mmol/l glucose and then returned
to 2.5 mmol/l glucose for 15 min. Values are means±SEM of three
independent experiments. *p<0.05, **p<0.01 for corresponding time
points. Glc, glucose
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immunoprecipitation assay. The RE-1s of the Snap25, Syt4,
Syt7, Nsf and Cplx2 genes were immunoprecipitated with
the antibodies against REST (Fig. 5b), confirming the
functional properties of these RE-1 sequences. In contrast
the RE-1 of Munc18-1 was not enriched in the cells trans-
duced for REST, consistent with the more variable sequence
of this RE-1 motif (Fig. 5a).
RESTrepresses a subset of genes implicated in exocytosis The
effect of REST binding to RE-1s was assessed on several
endogenous transcripts of INS-1E cells. A transcriptional
repression was observed for the Snap25, Syt4, Syt7, Syt9
and Cplx2 genes, but not for the genes coding for NSF and
MUNC18-1 (Fig. 6a). The signal for the Syt7 gene, which
is subjected to alternative splicing [24], corresponds to the
most abundant Syt7a splice variant. The negative regulation
of Cx36 [11] is shown as a control. The expression levels of
several genes lacking RE-1, including those coding for t-
Fig. 6 REST downregulates the expression of several genes coding
for proteins of the exocytotic machinery. a, b Northern blot of mRNA
from wild-type (NI) and transduced (Ad-GFP, Ad-REST) INS-1E
cells, displaying (a) the transcriptional downregulation of genes with
identified RE-1 sequence and (b) the transcript levels of genes that
lack RE-1 and which encode other proteins of the exocytotic
machinery, insulin and mitochondrial Glud1. β-actin mRNA signals
served as internal control. c Quantitative RT-PCR analysis of mRNA
levels of putative target genes in mouse islets transduced with Ad-GFP
(white columns) and Ad-REST (black columns). Results are mean
±SEM of four independent experiments. d Quantitative RT-PCR
analysis of mRNA levels of putative REST target genes from islets of
wild-type (white columns) (n=6) and RIP–REST (black columns) (n=
10) mice. Results are mean±SEM. *p<0.05, **p<0.01, ***p<0.001
Fig. 5 Several genes coding for proteins of the exocytotic machinery
have functional RE-1 binding sites. a Alignment of identified human
(Hum) RE-1 sequences with consensus RE-1 and the functional Cx36
RE-1. The SNAP25 gene contains two consecutive RE-1s referred to as
RE-1.1 and RE-1.2. b Chromatin immunoprecipitation assay compar-
ing wild-type (NI) and REST-transduced INS-1E cells (Ad-REST).
PCR amplification of the indicated genes showed enrichment of the
RE-1 flanking sequences in chromatin immunoprecipitated with anti-
REST antibodies (REST) compared with irrelevant anti-SREBP-1
antibodies (IR). Non-precipitated chromatin (INPUT) is shown as
control. Results are representative of three independent experiments
Diabetologia (2008) 51:1429–1439 1435
SNARE syntaxin 1A, v-SNARE vesicle-associated mem-
brane protein 2 (VAMP2), α- and β-soluble NSF attach-
ment protein, small GTP-binding protein RAB3A, member
RAS oncogene family (RAB3A), Glud1 gene encoding
mitochondrial glutamate dehydrogenase (GDH), and insulin
were not modulated by REST (Fig. 6b). Quantitative RT-
PCR revealed a similar transcription pattern in islets
transduced for REST (Fig. 6c) or isolated from RIP–REST
mice (Fig. 6d). However, in contrast to the findings in
transiently transduced INS-1E cells and islets, the constitu-
tive expression of REST in islets from transgenic mice was
also associated with lower levels of insulin mRNA (Fig. 6d).
To assess whether these transcriptional changes affected the
levels of the cognate proteins, we performed western blots
with total extracts of transduced INS-1E cells (Fig. 7a) and of
islets isolated from RIP–REST mice, where REST was
declared as a 210 kDa immunoreactive band (Fig. 7b). In
both cases, the presence of REST decreased the levels of
SNAP25 and SYT IV proteins, detected as immunoreactive
bands of 25 and 45 kDa, respectively. CX36 is shown as a
positive control [11].
SYT IV or SYT VII silencing inhibits hormone secretion To
clarify the role of SYT IV and SYT VII in insulin secretion,
we used a plasmid directing the expression of a specific
siRNA and of hGH as a reporter gene. We compared the
effect of three constructs, containing either a siRNA specific
to the Syt4 isoform (siRNA Syt4), to all Syt7 splice variants
(siRNA Syt7) or, as a negative control, to human REST
(siRNA REST). The silencing efficiency of each construct
was checked at the transcript levels of target genes fused to
luciferase reporter gene (data not shown). The effect of
SYT silencing on hGH secretion was assessed in trans-
fected INS-1E cells, stimulated with a mixture of 15 mmol/l
glucose, 10 μmol/l forskolin and 100 μmol/l IBMX (Fig. 8).
Under these conditions, the control cells transfected with
pXGH alone showed a fourfold increase in the release of
hGH. The selective knockdown of either SYT IV or SYT
VII did not significantly alter basal secretion, but inhibited
hGH release by 60 and 50%, respectively (Fig. 8). The
transfection of pXGH together with a plasmid coding for
human REST, also resulted in a 40% decrease in the stim-
ulated hGH secretion, whereas the transfection of siRNA
REST did not alter hGH release. These data show that SYT
IV and SYT VII contribute to the control of insulin release.
Discussion
Through its loss of function at different stages of neural
differentiation, the transcriptional repressor REST plays a
Fig. 8 SYT IVor SYT VII silencing inhibits hormone secretion. hGH
release in INS-1E cells transiently transfected with a plasmid encoding
hGH alone (Control [Ctrl]) or with a plasmid encoding hGH together
with either the siRNA Syt4, the siRNA Syt7 or the siRNA REST.
Secretion was monitored under basal conditions (white columns) and
after stimulation by 15 mmol/l glucose plus 10 μmol/l forskolin and
100 μmol/l IBMX (black columns). Silencing of either SYT isoforms
or REST expression reduced the stimulated hGH release. Results are
mean±SEM of three independent experiments. *p<0.05, **p<0.01
and ***p<0.001 versus values of respective basal conditions; †p<
0.01 versus values of stimulated control condition
Fig. 7 REST downregulates the expression of selected protein. a
Immunoblotting of total protein from wild-type (NI) and transduced
(Ad-GFP, Ad-REST) INS-1E cells showed the decreased levels of
SNAP-25 and SYT IV proteins in REST-expressing cells. CX36 levels
are shown as a positive control. b Immunoblotting of total proteins
from islets isolated from wild-type (WT) (n=3) and RIP–REST (n=3)
mice. An immunoreactive band for REST (210 kDa) was found in
RIP–REST but not in control islets. CX36, SNAP25 and SYT IV
abundance were reduced in RIP–REST animals
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strategic role in the specification of the neuronal phenotype,
[25]. The absence of REST from mature pancreatic beta
cells also assigns to this cell type a specific pattern of genes,
termed neuronal traits [10]. Recently, these traits have been
implicated in the functioning of a transformed pancreatic beta
cell line [1]. However, it has not been elucidated whether any
of these genes is directly involved in primary beta cell func-
tion and if so, through which mechanism. In the present
study, we show that the target genes of REST are crucial for
proper function of adult primary beta cells, inasmuch as a
gain of REST function impairs first and second phases of
insulin secretion. Our data suggest that REST controls a step
of the stimulus–secretion coupling pathway, which is down-
stream of the elevation of intracellular Ca2+ and common to
both first and second phases of insulin secretion. We hypo-
thesised that it may be related to vesicle trafficking and/or
fusion. Accordingly, we found that REST repressed the ex-
pression of several genes coding for proteins of the exocytotic
machinery, including SNAP25, SYT IV, SYT VII, SYT IX
and complexin II. The exocytosis of insulin-containing LDCV
resembles that of neuronal synaptic vesicles [26] and employs
a similar broad set of proteins, each of which plays a precise
role. In particular, a direct implication in the control of
insulin secretion has been established for several members of
the exocytotic machinery, including SNAP25 [27], NSF
[28], MUNC18–1 [29] and both SYT V and SYT IX [30].
However, the role of SYT IV and SYT VII in neurons and
pancreatic beta cells is still a matter of debate. In neuro-
endocrine PC12 cells, SYT IV has been identified as an
essential component for the maturation of secretory granules
[31]. This protein has also been reported to play a role in the
stabilisation of the fusion pore and in the choice between
kiss-and-run and full fusion events, for both synaptic vesicles
of PC12 and LDCVof MIN-6 cells [32, 33]. In PC12 cells,
SYT VII has also been implicated in the exocytosis of
synaptic vesicle [19, 34, 35], whereas in beta cells this
protein may be implicated in endocytotic traffic and insulin
exocytosis [36, 37]. Using specific siRNAs, we confirm the
recently published data on the role of SYT VII in insulin
secretion [37] and show that SYT IV also plays a significant
role in the control of insulin release from INS-1E cells.
The integrity of the exocytotic machinery is critical for
glucose homeostasis, as observed in the Goto–Kakisaki rat
model of type 2 diabetes and in type 2 diabetic patients, in
both of which the expression of SNARE proteins is decreased
[38, 39]. In view of the present knowledge on granule
dynamics and distinct pools, it has been speculated that the
proteins of the exocytotic machinery that are implicated in
the rate-limiting priming of secretory granules are strong
candidates for the triggering of beta cell dysfunctions as-
sociated with type 2 diabetes [40]. In the RIP–REST
transgenic mice that specifically express REST in beta cells,
expression of multiple REST target genes, including those
coding for the major proteins controlling exocytosis, was
decreased. This model provides a unique opportunity to
assess, in vivo, the function of REST-dependent genes. We
observed that these genes are critical for insulin secretion,
inasmuch as their downregulation resulted in loss of
glucose-dependent and glucose-independent insulin release
to a degree sufficient to cause glucose intolerance. In these
mice, the expression of REST did not alter the architecture
of pancreatic islets, but induced a reduction in the number of
beta cells. This effect is consistent with the anti-proliferative
action of REST, previously reported in tumoral transforma-
tion [41] and human neointimal hyperplasia [9]. The
reduced number of cells correlated with reduced expression
of the insulin gene and lower pancreatic content of the
hormone, which was not observed in INS1-E cells acutely
transduced for REST. This lower rate of insulin production
may be accounted for by the decreased insulin exocytosis
rate and/or the long term REST-induced repression of key
factors, such as the protein tyrosine phosphatase, receptor
type, N (ICA512). Upon exocytosis, this LDCV-associated
protein is cleaved and stimulates insulin synthesis through a
retrograde pathway in order to adjust insulin production to
its exocytosis [42]. The Ica512 gene is a bona fide RE-1
containing REST target gene, whose expression was
decreased in both REST-expressing INS-1E cells and islets
of RIP–REST transgenic mice (data not shown).
According to recent data on the genome-wide chromatin
occupancy mediated by REST in non neuroendocrine cells,
new target genes implicated in different cell functions
remain to be found and their effects evaluated [43, 44]. The
multiplicity of these genes and their functional interactions
make it necessary to perform comprehensive studies using
gene array-based analyses of RIP–REST mice. Such studies
should identify which of these genes is key to beta cell
identity, insulin secretion and beta cell survival. Such a
comprehensive analysis was beyond the scope of our study
and will be the topic of future experiments.
In summary, using an innovative approach of ectopic REST
expression in beta cells, we have identified several target
genes that significantly contribute to the in vitro and in vivo
control of glucose-stimulated insulin secretion. Our findings
document the physiological importance of the native down-
regulation of REST in beta cells and possibly in other
neuroendocrine cells [45] with a view to maintaining normal
secretion by regulating the levels of key exocytotic proteins.
Our findings point to the RIP–REST transgenic mice as a
pertinent model for the identification of other REST target
genes that may play a critical role in the pathophysiology of
glucose intolerance and, possibly, of diabetes.
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